Chinese Journal of Antituberculosis ›› 2024, Vol. 46 ›› Issue (1): 85-91.doi: 10.19982/j.issn.1000-6621.20230329
• Original Articles • Previous Articles Next Articles
Kong Hanhan1, Zhang Jiaohong2, Zeng Jianfeng2, Cao Jing3()
Received:
2023-09-08
Online:
2024-01-10
Published:
2024-01-04
Contact:
Cao Jing, Email: Supported by:
CLC Number:
Kong Hanhan, Zhang Jiaohong, Zeng Jianfeng, Cao Jing. Construction and validation of frailty risk prediction model in elderly patients with pulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2024, 46(1): 85-91. doi: 10.19982/j.issn.1000-6621.20230329
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20230329
项目 | 无衰弱组(219例) | 衰弱组(229例) | 统计检验值 | P值 |
---|---|---|---|---|
年龄[岁,M(Q1,Q3)] | 68(63,72) | 72(66,79) | Z=-5.839 | <0.001 |
BMI( | 20.49±3.05 | 19.34±3.52 | t=3.700 | <0.001 |
ADL[分,M(Q1,Q3)] | 100(90,100) | 70(50,95) | Z=-9.440 | <0.001 |
有无配偶[例(构成比,%)] | χ2=4.793 | 0.029 | ||
有 | 201(91.8) | 195(85.2) | ||
无 | 18(8.2) | 34(14.8) | ||
吸烟[例(构成比,%)] | χ2=4.217 | 0.040 | ||
是 | 78(35.6) | 61(26.6) | ||
否 | 141(64.4) | 168(73.4) | ||
痰菌情况 | χ2=5079 | 0.024 | ||
阴性 | 80(36.5) | 61(26.6) | ||
阳性 | 139(63.5) | 168(73.4) | ||
病程[月,M(Q1,Q3)] | 1(0.5,2) | 1(0.5,3) | Z=-4.108 | <0.001 |
用药[种,M(Q1,Q3)] | 7(5,9) | 8.5(6,11) | Z=-5.106 | <0.001 |
血红蛋白[g/L,M(Q1,Q3)] | 113(102,127) | 106.5(91,120) | Z=-3.472 | 0.001 |
白细胞计数[×109/L,M(Q1,Q3)] | 6.23(4.99,7.63) | 7.17(5.53,9.32) | Z=-4.040 | <0.001 |
白蛋白[g/L,( | 36.78±4.78 | 34.17±5.30 | t=5.487 | <0.001 |
hs-CRP[mg/L,M(Q1,Q3)] | 20.52(4.46,52.82) | 43.06(11.08,77.61) | Z=-5.061 | <0.001 |
并发症指数[M(Q1,Q3)] | 2(1,3) | 2(2,3) | Z=-3.617 | <0.001 |
社会支持[分,M(Q1,Q3)] | 59.5(45,69) | 55(42,67) | Z=-2.260 | 0.024 |
抑郁[分,M(Q1,Q3)] | 5(3,9.25) | 12(7,16) | Z=-8.648 | <0.001 |
病耻感[分,M(Q1,Q3)] | 6(2,11) | 9(5,14) | Z=-3.760 | <0.001 |
自我管理(分, | 27.48±6.04 | 23.95±5.74 | t=6.333 | <0.001 |
变量 | β值 | s | Wald χ2值 | P值 | OR(95%CI)值 |
---|---|---|---|---|---|
并发症指数 | 0.390 | 0.114 | 11.623 | 0.001 | 1.477(1.180~1.849) |
年龄 | 0.052 | 0.017 | 9.671 | 0.002 | 1.054(1.020~1.089) |
ADL | -0.031 | 0.006 | 23.587 | 0.000 | 0.970(0.958~0.982) |
病程 | 0.088 | 0.038 | 5.237 | 0.022 | 1.092(1.013~1.177) |
痰菌情况 | 0.650 | 0.266 | 5.955 | 0.015 | 1.916(1.136~3.229) |
抑郁 | 0.105 | 0.022 | 22.871 | 0.000 | 1.110(1.064~1.159) |
自我管理 | -0.058 | 0.023 | 6.643 | 0.010 | 0.944(0.903~0.986) |
hs-CRP | 0.007 | 0.002 | 8.040 | 0.005 | 1.007(1.002~1.011) |
白细胞计数 | 0.121 | 0.046 | 6.932 | 0.008 | 1.129(1.031~1.235) |
常量 | -3.251 | 1.625 | 4.003 | 0.045 |
[1] | 中华医学会.肺结核基层诊疗指南(2018年). 中华全科医师杂志, 2019, 18(8): 709-717. doi:10.3760/cma.j.issn.1671-7368.2019.08.002. |
[2] | 彭希哲. 老龄化背景下的人口年龄结构. 上海交通大学学报(哲学社会科学版), 2023, 31(2): 14-24. doi:10.13806/j.cnki.issn1008-7095.2023.02.002. |
[3] | Gupta S, Arora V, Sharma OP, et al. Prevalence & pattern of respiratory diseases including Tuberculosis in elderly in Ghaziabad-Delhi-NCR. Indian J Tuberc, 2016, 63(4): 236-241. doi:10.1016/j.ijtb.2016.09.012. |
[4] | Hosford JD, von Fricken ME, Lauzardo M, et al. Hepatotoxi-city from antituberculous therapy in the elderly: a systematic review. Tuberculosis (Edinb), 2015, 95(2): 112-122. doi:10.1016/j.tube.2014.10.006. |
[5] |
Hase I, Toren KG, Hirano H, et al. Pulmonary Tuberculosis in Older Adults: Increased Mortality Related to Tuberculosis Within Two Months of Treatment Initiation. Drugs Aging, 2021, 38(9):807-815. doi:10.1007/s40266-021-00880-4.
pmid: 34224105 |
[6] | Shaik KU, Dattu MS, Suresh R, et al. A prospective study of pulmonary tuberculosis in rural geriatric population of South India. J Clini Sci Res, 2016, 5(1):29-32. doi:10.15380/2277-5706.JCSR.15.043. |
[7] | 褚娇娇, 陈旭娇, 严静. 亚太老年人衰弱管理临床实践指南解读. 中华老年医学杂志, 2019, 38(11): 1213-1214. doi:10.3760/cma.j.issn.0254-9026.2019.11.005. |
[8] | Buckinx F, Rolland Y, Reginster JY, et al. Burden of frailty in the elderly population: perspectives for a public health challenge. Arch Public Health, 2015, 73(1): 19. doi:10.1186/s13690-015-0068-x. |
[9] |
Evans WJ, Paolisso G, Abbatecola AM, et al. Frailty and muscle metabolism dysregulation in the elderly. Biogerontology, 2010, 11(5): 527-536. doi:10.1007/s10522-010-9297-0.
pmid: 20683658 |
[10] | 杨学英. 肺结核患者肌肉减少症的相关研究. 天津:天津医科大学, 2020. doi:10.27366/d.cnki.gtyku.2020.000371. |
[11] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 2017-11-09. |
[12] | 曹春乐. 老年肺结核患者衰弱现状及影响因素研究. 长沙:湖南师范大学, 2021. doi:10.27137/d.cnki.ghusu.2021.002915. |
[13] |
Vergouwe Y, Steyerberg EW, Eijkemans MJ, et al. Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. J Clin Epidemiol, 2005, 58(5): 475-483. doi:10.1016/j.jclinepi.2004.06.017.
pmid: 15845334 |
[14] |
Lopez D, Flicker L, Dobson A. Validation of the frail scale in a cohort of older Australian women. J Am Geriatr Soc, 2012, 60(1): 171-173. doi:10.1002/hpm.3684.
pmid: 22239307 |
[15] | 孔含含, 刘燕群, 操静, 等. 获得性免疫缺陷综合征住院病人衰弱现状及影响因素分析. 全科护理, 2022, 20(14): 1987-1990. doi:10.12104/j.issn.1674-4748.2022.14.034. |
[16] | 杨婷婷, 龚言红, 殷晓旭, 等. 结核病相关病耻感量表的研制与评价. 公共卫生与预防医学, 2016, 27(6): 46-48. |
[17] | Costantini L, Pasquarella C, Odone A, et al. Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): A systematic review.Journal of Affective Disorders, 2021, 279: 473-483. doi:10.1016/j.jad.2020.09.131. |
[18] | 谈迪心, 王斌, 李绪辉, 等. 老年结核病患者自我健康管理评定量表的信效度研究. 中国全科医学, 2017, 20(34): 4299-4303. doi:10.3969/j.issn.1007-9572.2017.34.017. |
[19] | Zimet GD, Powell SS, Farley GK, et al. Psychometric characteristics of the Multidimensional Scale of Perceived Social Support. J Pers Assess, 1990, 55(3/4): 610-617. doi:10.1080/00223891.1990.9674095. |
[20] | 许丽娟, 张丽虹, 叶丽娜, 等. 社区老年衰弱危险因素及风险预测模型构建. 中国老年学杂志, 2021, 41(1): 170-173. doi:10.3969/j.issn.1005-9209.2021.01.048. |
[21] | Kojima G, Iliffe S, Taniguchi Y, et al. Prevalence of frailty in Japan: A systematic review and meta-analysis.J Epidemiol, 2017, 27(8): 347-353. doi:10.1016/j.je.2016.09.008. |
[22] | 卢歆韵, 梁汉成, 张元镇, 等. 老年肺结核患者应用抗结核药物的不良反应分析. 深圳中西医结合杂志, 2021, 31(22): 138-140. doi:10.16458/j.cnki.1007-0893.2021.22.052. |
[23] | 王龙, 曾繁文, 肖方志, 等. 2020—2021年三明市肺结核患者抗结核药物的应用现状及不良反应发生情况分析. 临床合理用药杂志, 2022, 15(21): 163-166. doi:10.15887/j.cnki.13-1389/r.2022.21.051. |
[24] | 任鹏飞, 陈裕, 陈永芳, 等. 300例60岁以上的肺结核患者及SCL-90评分现况调查相关影响因素分析. 黑龙江医学, 2021, 45(13): 1435-1437. doi:10.3969/j.issn.1004-5775.2021.13.034. |
[25] | 马丽娜. 老年衰弱综合征的发病机制. 中华老年医学杂志, 2021, 40(3): 379-382. doi:10.3760/cma.j.issn.0254-9026.2021.03.023. |
[26] | 景海蓉, 陈雅雯, 付泓博, 等. 肌少症的血清生物标志物. 中华老年多器官疾病杂志, 2022, 21(8): 616-620. doi:10.11915/j.issn.1671-5403.2022.08.133. |
[27] | 徐静, 罗萍, 贺晓新. 肺结核合并糖尿病与单纯肺结核患者流行特征对比分析. 中国防痨杂志, 2022, 44(5): 494-499. doi:10.19982/j.issn.1000-6621.20220047. |
[28] | 胡瑞娟, 邱莉霞. 老年肺结核患者服药依从性的多因素分析与护理措施. 护理实践与研究, 2020, 17(11): 20-22. doi:10.3969/j/issn.1672-9676.2020.11.007. |
[29] | 王媛媛. 老年慢性阻塞性肺疾病患者社会支持、自我管理与衰弱的相关性研究. 吉林:北华大学, 2022. doi:10.26928/d.cnki.gbhuu.2022.000052. |
[30] |
Tarazona-Santabalbina FJ, Gomez-Cabrera MC, Perez-Ros P, et al. A Multicomponent Exercise Intervention that Reverses Frailty and Improves Cognition, Emotion, and Social Networking in the Community-Dwelling Frail Elderly: A Randomized Clinical Trial. J Am Med Dir Assoc, 2016, 17(5): 426-433. doi:10.1016/j.jamda.2016.01.019.
pmid: 26947059 |
[31] | 王会会, 王君俏, 谢博钦, 等. 基于整合照料理念的活动方案对养老机构非卧床老年人衰弱干预的研究. 护士进修杂志, 2020, 35(21): 1946-1949. doi:10.16821/j.cnki.hsjx.2020.21.007. |
[1] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[2] | Liu Juxiu, Zhang Jianhua, Wen Junjun, Jiang Xiaoshuang. Analysis and trend prediction of Mycobacterium tuberculosis drug resistance in Jilin City [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 348-354. |
[3] | Zhao Yue, Wang Haoran, Cheng Meijin, Wang Wei, Liang Ruixia, Huang Hairong. The evaluation of the smear-positive and Xpert-negative outcome as an early indicator of nontuberculous mycobacteria existence in clinical specimen [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 61-65. |
[4] | Liu Ling, Zeng Yi, Wang Jin, Liu Xiaoling, Liu Yan, Lin Feishen, Guo Jing. Construction and evaluation of a model for predicting malnutrition in patients with pulmonary tuberculosis and diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 903-909. |
[5] | Gao Lei, Liang Yaxue, Liu Shengsheng, Wang Hua. Analysis of treatment outcomes and influencing factors in 144 elderly patients with rifampicin drug-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(7): 799-807. |
[6] | Geng Junling, Zhang Yinan, Pan Hongqiu. Establishment and validation of a risk prediction model for drug-induced liver injury in patients with tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 699-706. |
[7] | Teng Chong, Wang Yulan, Liu Liu, Zhang Fang, Huang Fei, Li Tao, Zhao Bing, Zhao Yanlin, Ou Xichao. Analysis of the epidemiological characteristics and prediction for the reported incidence of pulmonary tuberculosis in Dongcheng District, Beijing from 2013 to 2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 397-402. |
[8] | Yang Chao, Wang Jing, Yang Chaohui, Gao Hanqing. Analysis of the epidemiological characteristics and treatment outcomes of pulmonary tuberculosis aged ≥60 years old in Tongzhou District of Beijing, 2016—2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 403-410. |
[9] | Xu Henan, Lai Congjuan, Zhang Zunjing, Guo Jing, Xu Lixia, Zhang Ying, Liu Zhongda. Analysis of drug resistance in clinical isolates from 610 elderly tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1490-1495. |
[10] | Zhou Wenyong, Wen Zexuan, Gao Mengxian, Li Tao, Zhang Hui, Wang Weibing. Prediction of the effectiveness and impact of the free healthcare policy for tuberculosis in China [J]. Chinese Journal of Antituberculosis, 2023, 45(9): 845-856. |
[11] | Ren Feilin, Liu Xiaoqi, Jin Meihua, Sun Xiuxiu. Study on the predictive effect of seasonal auto regressive integrated moving average model on the incidence of pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(5): 514-519. |
[12] | Teng Rencong, Li Tao, LI Yuhong, Yang Chenlu, Zhang Canyou, Zhao Yanlin, Zhang Hui. Analysis of registration records of elderly pulmonary tuberculosis patients aged 65 and above in China,2015—2021 [J]. Chinese Journal of Antituberculosis, 2023, 45(4): 367-371. |
[13] | Sun Minghao, Duan Yuqi, Zheng Liang, Yu Shengnan, Cheng Chuanlong, Zuo Hui, Chen Ming, Li Xiujun. Application of ARIMA, ARIMAX, and NGO-LSTM models in forecasting the incidence of tuberculosis cases in Liaocheng City, Shandong Province [J]. Chinese Journal of Antituberculosis, 2023, 45(12): 1177-1185. |
[14] | Chen Daiquan, Lin Shufang, Dai Zhisong, Zhou Yinfa, Chen Kun. Construction and validation of a nomogram for predicting unfavorable treatment outcomes among patients with rifampicin-sensitive tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(10): 957-966. |
[15] | Zhu Ping, Hao Xiaogang, Wang Wei, Chen Bin. Epidemiological characteristics of inactive pulmonary tuberculosis among the elderly in high-endemic rural areas in Quzhou City, Zhejiang Province [J]. Chinese Journal of Antituberculosis, 2022, 44(8): 815-820. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||